Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10286837 | 0.85 | KMT2A (0.48) | KMT2AL3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL527288 | 0.85 | KMT2A (0.48) | KMT2AL3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL10286126 | 0.82 | KMT2A (0.44) | KMT2AL3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL20081487 | 0.82 | KMT2A (0.43) | KMT2AL3MBTL1THRBKDM4EALDH1A1 | |
| SCHEMBL883090 | 0.81 | KMT2A (0.45) | KMT2AL3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL883079 | 0.76 | KMT2A (0.44) | KMT2AL3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL28902024 | 0.75 | PDE4B (0.49) | KMT2AL3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL883086 | 0.74 | KMT2A (0.53) | KMT2AL3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL14064439 | 0.74 | THRB (0.44) | KMT2ATHRBKDM4EALDH1A1MEN1 | |
| SCHEMBL10286170 | 0.73 | KMT2A (0.41) | KMT2AL3MBTL1KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180102484-A1 | NEW COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-04-12 | — | — | US | disclosed |
| US-20180102484-A1 | NEW COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-04-12 | — | — | US | disclosed |
| US-9871206-B2 | Compound, organic electroluminescence device material, organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-01-16 | — | — | US | disclosed |
| EP-2072517-B1 | Asymmetric phenanthrolins, method for their manufacture and doped organic semiconductor material containing them | NOVALED GMBH (DE) | 2015-01-21 | — | — | EP | disclosed |
| EP-2072517-B1 | Asymmetric phenanthrolins, method for their manufacture and doped organic semiconductor material containing them | NOVALED GMBH (DE) | 2015-01-21 | — | — | EP | disclosed |
| US-20140309244-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-10-16 | — | — | US | disclosed |
| US-20140309244-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-10-16 | — | — | US | disclosed |
| US-20140162980-A1 | NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES | SYNGENTA CROP PROTECTION LLC (US) | 2014-06-12 | — | — | US | disclosed |
| US-20140162980-A1 | NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES | SYNGENTA CROP PROTECTION LLC (US) | 2014-06-12 | — | — | US | disclosed |
| WO-2013139822-A1 | NOVEL BISOXIME MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2013-09-26 | — | — | WO | disclosed |
| EP-2194055-A1 | Bridged pyridoquinazoline or phenanthroline compounds and organic semiconducting material comprising that compound | Novaled AG (DE) | 2010-06-09 | — | — | EP | disclosed |
| WO-2009083197-A2 | ASYMMETRIC PHENANTHROLINES, PREPARATION PROCESS THEREFORE AND DOPED ORGANIC SEMICONDUCTOR MATERIAL CONTAINING THEM | NOVALED AG (DE) | 2009-07-09 | — | — | WO | disclosed |
| WO-2009083197-A2 | ASYMMETRIC PHENANTHROLINES, PREPARATION PROCESS THEREFORE AND DOPED ORGANIC SEMICONDUCTOR MATERIAL CONTAINING THEM | NOVALED AG (DE) | 2009-07-09 | — | — | WO | disclosed |
| EP-2072517-A1 | Asymmetric phenanthrolins, method for their manufacture and doped organic semiconductor material containing them | Novaled AG (DE) | 2009-06-24 | — | — | EP | disclosed |
| EP-2072517-A1 | Asymmetric phenanthrolins, method for their manufacture and doped organic semiconductor material containing them | Novaled AG (DE) | 2009-06-24 | — | — | EP | disclosed |
| US-20080227979-A1 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these | NOVALED AG (DE) | 2008-09-18 | — | — | US | disclosed |
| US-20080227979-A1 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these | NOVALED AG (DE) | 2008-09-18 | — | — | US | disclosed |
| US-20080227979-A1 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these | NOVALED AG (DE) | 2008-09-18 | — | — | US | disclosed |
| EP-1970371-A1 | Pyrido(3,2-h)chinazolins and/or 5,6-Dihydro derivatives thereof, method for their manufacture and endowed organic semiconductor material containing them | Novaled AG (DE) | 2008-09-17 | — | — | EP | disclosed |
| EP-1970371-A1 | Pyrido(3,2-h)chinazolins and/or 5,6-Dihydro derivatives thereof, method for their manufacture and endowed organic semiconductor material containing them | Novaled AG (DE) | 2008-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140309244-A1 | NOVEL MICROBIOCIDES | MSR1, C3AR1, CD209 | KMT2A 3934/4885L3MBTL1 1422/4885THRB 4735/4885 |
| US-20080227979-A1 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these | PDXK, PNPO, QDPR | KMT2A 1104/4885L3MBTL1 4319/4885THRB 4785/4885 |
| US-20180102484-A1 | NEW COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | CBX8, MLX, HAX1 | KMT2A 1095/4885L3MBTL1 2276/4885THRB 3988/4885 |
| US-20140162980-A1 | NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES | PRDX4, PRDX6, DDT | KMT2A 1798/4885L3MBTL1 773/4885THRB 4586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.